TrialAnnals of clinical and translational neurology2025

Durability of Response to B-Cell Maturation Antigen-Directed mRNA Cell Therapy in Myasthenia Gravis.

Nizar Chahin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.